Symbio Pharmaceuticals Limited Announces Earnings Results for the Six Months Ended June 30, 2021
August 04, 2021 at 02:30 am EDT
SymBio Pharmaceuticals Limited announced earnings results for the six months ended June 30, 2021. For the six months, the company reported net sales of JPY 3,146,608,000 compared to JPY 1,360,648,000 a year ago. Operating loss was JPY 194,941,000 compared to JPY 1,839,942,000 a year ago. Loss was JPY 205,560,000 or JPY 5.37 per share compared to JPY 1,884,976,000 or JPY 62.47 per share a year ago.